Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hyunki Kim

Showing results (211-220 of 243) with videos related to

Pageof 25
Sort By:
Nature Communications|October 12, 2022
A single arm phase Ib/II trial of first-line pembrolizumab, trastuzumab and chemotherapy for advanced HER2-positive gastric cancerChoong-Kun Lee, Sun Young Rha, Hyo Song Kim, et al.
JCI Insight|October 5, 2016
A ferret model of COPD-related chronic bronchitisS Vamsee Raju, Hyunki Kim, Stephen A Byzek, et al.
British Journal of Cancer|April 7, 2023
Tumour infiltrating lymphocytes and survival after adjuvant chemotherapy in patients with gastric cancer: post-hoc analysis of the CLASSIC trialDrolaiz H W Liu, Young-Woo Kim, Nina Sefcovicova, et al.
Oncotarget|April 21, 2016
PIK3CA amplification is associated with poor prognosis among patients with curatively resected esophageal squamous cell carcinomaHyo Song Kim, Seung Eun Lee, Yoon Sung Bae, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|October 31, 2023
Second-line chemoimmunotherapy with nivolumab and paclitaxel in immune-related biomarker-enriched advanced gastric cancer: a multicenter phase Ib/II studyChoong-Kun Lee, Jii Bum Lee, Se Jung Park, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|February 19, 2025
Spatial organization of B lymphocytes and prognosis prediction in patients with gastric cancerRyan Yong Kiat Tay, Manavi Sachdeva, Haoran Ma, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|May 16, 2025
Correction: Spatial organization of B lymphocytes and prognosis prediction in patients with gastric cancerRyan Yong Kiat Tay, Manavi Sachdeva, Haoran Ma, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 26, 2023
Trastuzumab Combined With Ramucirumab and Paclitaxel in Patients With Previously Treated Human Epidermal Growth Factor Receptor 2-Positive Advanced Gastric or Gastroesophageal Junction CancerChang Gon Kim, Minkyu Jung, Hyo Song Kim, et al.
Genome Research|August 26, 2025
APOBEC3A drives deaminase mutagenesis in human gastric epitheliumYohan An, Ji-Hyun Lee, Joonoh Lim, et al.
Cancer Research and Treatment|February 27, 2015
Prognostic Significance of Defining L-Cell Type on the Biologic Behavior of Rectal Neuroendocrine Tumors in Relation with Pathological Parameters, Jin Hee Sohn, Mee-Yon Cho, et al.
Pageof 25

Showing results (211-220 of 243) with videos related to

Sort By:
Pageof 25
Nature Communications|October 12, 2022
A single arm phase Ib/II trial of first-line pembrolizumab, trastuzumab and chemotherapy for advanced HER2-positive gastric cancerChoong-Kun Lee, Sun Young Rha, Hyo Song Kim, et al.
JCI Insight|October 5, 2016
A ferret model of COPD-related chronic bronchitisS Vamsee Raju, Hyunki Kim, Stephen A Byzek, et al.
British Journal of Cancer|April 7, 2023
Tumour infiltrating lymphocytes and survival after adjuvant chemotherapy in patients with gastric cancer: post-hoc analysis of the CLASSIC trialDrolaiz H W Liu, Young-Woo Kim, Nina Sefcovicova, et al.
Oncotarget|April 21, 2016
PIK3CA amplification is associated with poor prognosis among patients with curatively resected esophageal squamous cell carcinomaHyo Song Kim, Seung Eun Lee, Yoon Sung Bae, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|October 31, 2023
Second-line chemoimmunotherapy with nivolumab and paclitaxel in immune-related biomarker-enriched advanced gastric cancer: a multicenter phase Ib/II studyChoong-Kun Lee, Jii Bum Lee, Se Jung Park, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|February 19, 2025
Spatial organization of B lymphocytes and prognosis prediction in patients with gastric cancerRyan Yong Kiat Tay, Manavi Sachdeva, Haoran Ma, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|May 16, 2025
Correction: Spatial organization of B lymphocytes and prognosis prediction in patients with gastric cancerRyan Yong Kiat Tay, Manavi Sachdeva, Haoran Ma, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 26, 2023
Trastuzumab Combined With Ramucirumab and Paclitaxel in Patients With Previously Treated Human Epidermal Growth Factor Receptor 2-Positive Advanced Gastric or Gastroesophageal Junction CancerChang Gon Kim, Minkyu Jung, Hyo Song Kim, et al.
Genome Research|August 26, 2025
APOBEC3A drives deaminase mutagenesis in human gastric epitheliumYohan An, Ji-Hyun Lee, Joonoh Lim, et al.
Cancer Research and Treatment|February 27, 2015
Prognostic Significance of Defining L-Cell Type on the Biologic Behavior of Rectal Neuroendocrine Tumors in Relation with Pathological Parameters, Jin Hee Sohn, Mee-Yon Cho, et al.
Pageof 25